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Abstract: Artemisinin (ART) is a sesquiterpene lactone and a popular malaria drug with potential
anticancer properties. In this work, LC/TOF/MS, was used to investigate the reaction of ART
with DNA bases. ART-deoxyadenosine and ART-deoxycytidine interactions, were studied in the
presence of iron II ions. ART-deoxyadenosine and ART-deoxycytidine reaction mixtures gave
chromatographic signatures that remained fairly unchanged at room temperature but grew after
incubation at 37 ◦ C. The change in temperature from room temperature to 37 ◦ C was the main driver
of adduct formation in these reactions. ART was found to react with Fe(II) ions as observed from
several new chromatographic peaks. ART-deoxyadenosine as well as ART-deoxycytidine in the
presence of Fe(II) ions resulted in formation of new chromatographic signatures of adducts consisting
of DNA bases and ART. It was clear that addition of iron (II) to DNA base-ART mixtures gave rise to
new reaction products mediated by a different reaction mechanism. Studies of ART reactions with
DNA in vitro is key in elucidating elusive mechanism of this drug.
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1. Introduction

MS Separation of Reaction Products.

Artemisinin (ART) is a sesquiterpene lactone consisting of an internal peroxide bridge
also known as a 1,2,4-trioxane ring system [1]. ART is effective against malaria, a disease
caused by the Plasmodium falciparum parasite [2]. Due to its low solubility and short
half-life, other semi-synthetic derivatives have been developed [3]. Dihydro-artemisinin,
one of the semi-synthetic form of ART, was derived from the primary active metabolite of
ART [4]. Other first generation semi-synthetic forms of ART are arteether and artemether
(lipid soluble), and artesunate (water soluble) [5].
Several studies and case reports show ART exhibiting anticancer properties against
cancer cells [6,7] as well as providing enhanced synergistic activity with other anti-cancer
agents [8]. The mechanism of action of ART is not well understood. However, the endoperoxide bridge of ART is thought to play a key role in the overall mechanism of action [9].
Interaction of the endo-peroxide of ART with heme in proteins is speculated to form free
radicals causing cell injury and apoptosis in cells [10]. The formation of carbon centered
free radicals when ART interacts with heme proteins is well known [11]. However, some
research indicates that ART and its derivatives go through Fenton-like reactions to kill
cancer cells [12,13]. ART has been reported to exhibit antileishmanial activity in particular
against visceral leishmaniasis [14]. New reports indicate that this drug can be used as an
anti-mycobacterial [15]. Despite ART’s potential uses and decades of research, knowledge
gaps concerning its mechanism and its specific targets remain glaring. For example, in a
new pharmacophoric study on the role of the peroxide bond in dioxanes against Leishmania
parasites no role was found for the peroxide bridge [16]. In fact, tetrahydropyran, an
epoxide, was found to induce a higher increase in intracellular reactive oxygen species
(ROS) levels than its endoperoxide counterpart. This implied that generation of free
radicals by cleaving the O−O bond is not the main mechanism of action in these peroxides.
Presence of free iron also did not affect free radical generation [16] This is in contrast to
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multiple other studies done previously that indicated presence of Fe(II) ions, mainly from
be decomposition of heme, are paramount in artemisinin’s anti-Leishmania efficacy [17].
The anticancer effects of ART and its derivatives are due to the latter’s ability to induce
apoptosis through cellular processes including DNA damage. The iron-mediated cleavage
of the endoperoxide bridge in ART could trigger the formation of the carbon centered
radicals that can induce ferroptosis [18]. In general, Fe(II) in the presence of ART can
trigger generation of free radicals through a Fenton-type reaction. Studies on drug and
DNA interactions are important in chemotherapeutics [19]. Research into such interaction
can enhance understanding of the mechanisms involved by unravelling structural changes
undergone by the drug. Products of the reaction can also help tailor new therapies. A
rapid separation method to help unravel the reaction products as well as help qualitatively
identify the reaction products is key to the search for the reaction mechanisms.
The aim of the current work is to develop new chromatographic methods and use
them to investigate the reactions of ART with DNA bases, and to establish the role of
Fe(II). LC/TOF MS was used to establish the reaction products. Reaction of ART with any
DNA base is key in unravelling part of the mechanism involved in the drug’s anticancer
activity. For the first time, the LC/TOF MS technique was used to clearly show that ART’s
reaction with DNA bases followed a different mechanism from that which occurs in the
presence of Fe(II). The role of temperature in the activity of the drug towards the DNA
bases was also established.
2. Materials and Methods
2.1. Chemicals and Reagents
ART was purchased from Tokyo Chemical Company (TCI). DNA base (2-deoxyadenosine)
was purchased from sigma. DNA base (2-deoxycytidine) and Iron (II) Chloride were
purchased from Alfa Aesar. Methanol, acetonitrile, ammonium acetate and water, all
LC-MS grade, were purchased from VWR. Solutions of ART and its derivatives containing
20 mM Ammonium acetate: Methanol, 15:85 were prepared prior to each experiment. All
other chemicals were LC-MS grade.
2.2. Chromatographic Procedure
Standards of ART and DNA bases were analyzed using TOF/LC-MS. Separation of the
reaction products of ART-deoxyadenosine and ART–deoxycytidine were carried out using
Agilent Technologies, ZORBAX Extended C-18 column (2.1 × 50 mm) with 1.8 µm diameter
particles. An autosampler was used to inject the sample, and the temperature was set to
25 ◦ C. The mobile phase consisted of Methanol and water 70:30, respectively. The LC-MS
analysis was carried out using Agilent 6230 series LC-MS TOF unit. The chromatographic
run was performed under isocratic conditions at a flow rate of 0.300 mL/min. Every end
of the run was followed by a post run step that included flushing the column with mobile
phase for 5 min. The column temperature was set at 25 ◦ C.
2.3. Mass Spectrometer Procedure
Mass spectrometry detection for the LC/MS was with a TOF 6230 series set to Dual
AJS ESI positive ion mode. The settings of the mass spectrometer were as follows: scan
mode (standard), range (200–3000) m/z, threshold (200), nebulizer gas (40.0 psi), and dry
gas (8.0 L/min), dry temperature (325 ◦ C). The compound stability and trap drive level
were set to 100%. The MS/MS fragmentation amp was set to 175 V and the skimmer cone
at 65 V.
2.4. Sample Preparation
ART-DNA Reactions
Solid mixtures of ART and 2-deoxyadenosine were placed in a 5 mL volumetric
flask. In another 5 mL volumetric flask, ART and 2-deoxycytidine were added. A buffer
solution containing 15% ammonium acetate (20.0 mM) and 85% methanol was added to the
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two volumetric flasks containing the solid mixtures. The final concentration of ART was
1.4 × 10−2 M while that of 2-deoxyadenosine was 1.6 × 10−2 M. The final concentration
of 2-deoxycytidine was 1.8 × 10−2 M. Two more solutions were made following the same
procedure, but with 2 × 10−3 M Fe2+ . Equal mixtures of ART and 2-deoxyadenosine
were placed in a 5 mL volumetric flask, and 3 mL of Iron II chloride solution was added
to the solid mixture of ART and 2-deoxyadenosine. A buffer solution was then used to
make up the 5 mL volume mark. The concentrations of ART and 2-deoxyadenosine were
1.4 × 10−2 M and 1.6 × 10−2 M, respectively. The final solution contained 1.4 × 10−2 M
ART, 1.8 × 10−2 M 2-Deoxycytidine and 2 × 10−3 M Fe2+ . For analysis, 1 mL of the sample
mixture was drawn, filtered and transferred into individual vials. Comparisons were made
between solution mixtures left at room temperature versus those incubated at 37 ◦ C. Some
sample mixtures were incubated at 37 ◦ C for different lengths of times before analysis.
2.5. Optimization of the Reaction Conditions
The concentration of standards and the chromatographic procedures were adjusted
and optimized for the optimal reaction and elution of the reaction products. Initially,
the ART, 2-deoxyadenosine and 2-deoxycytidine standards were analyzed individually.
Various ratios of solvents were investigated in order to optimize solubility of both the ART
and DNA bases as well as to effectively separate samples. The ratio of the solvents for the
sample mixture preparation, 20 mM Ammonium acetate: methanol, was adjusted to 15:85
to facilitate the solubility of the DNA base with ART. Methanol and water were used as the
mobile phases for the LC-MS method; the water contained 0.1% formic acid. The ratio was
adjusted to 70:30 for proper elution of the standard and reaction products. A column with
the dimensions 2.1 × 50 mm, with 1.8 µm was used for faster and more precise separation
of the reaction products. In this experiment, the incubation temperature was set to 37 ◦ C
and the column temperature was maintained at 25 ◦ C. After optimization of the reaction
conditions, each analysis were carried out three times.
3. Results
3.1. ART-Deoxyadenosine
Figure 1 shows the chemical structure of ART and its derivatives. Reaction of ART
with deoxyadenosine was monitored by obtaining chromatograms of mixtures at room
temperature and at 37 ◦ C. Figure 2 shows chromatograms of the sample mixtures, first
analyzed immediately after mixing and then analyzed again each day for four days. On the
first day, only two chromatogram peaks corresponding to the two reactants were obtained,
at or around retention times 0.4 and 1.3 min. On the third day of incubation at 37 ◦ C
new chromatographic peaks at retention times, 0.7, 0.8, 0.9, 1.1 and 1.2 min were visible.
Although the intensities of these peaks were very small, they signify formation of new
molecules between ART and deoxyadenosine. These new chromatographic reaction product peaks grew with time of incubation, while the parent reactant peaks reduced. The initial
reactant signature peaks decreased by about 17 ± 2% to 30 ± 4%, while the new product
peaks grew by about 41 ± 4% to 100 ± 5% during the time of incubation. Further analysis
of these reaction products was carried out using mass spectra. Mass spectra corresponding
to Figure 2 are shown in Figure S1 and indicate deoxyadenosine molecular ion [M+H]+ at
m/z 252. Other ions include [M+Na]+ , [M+ K]+ and [2M+Na]+ , corresponding to m/z of
274, 290 and 525, respectively. On the other hand ART, with a molecular weight of 282,
showed molecular ions of [M+H]+ at m/z 283, in addition to other ions such as [M+Na]+ ,
[M+K]+ , [2M+Na]+ , corresponding to m/z of 305, 321 and 587, respectively.
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Table 1. Retention time and fragmentation patterns of Deoxyadenosine reacted with artemisinin.
Retention Time

Main Fragments (m/z)

0.7

251, 337, 353, 399

0.8

237, 251, 307, 399

0.9

251, 307, 337, 353

1.1

251, 283, 305, 337, 353 and 587

1.2

209, 237, 251, 265, 337 and 353
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role of Fe2+, new reaction mixtures were made involving ART with Fe2+, 1.4 × 10ିଶ M and
2 × 10ିଷ M, respectively. Figure 4a shows the chromatograms of ART and Fe2+. ART by
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From the mass spectra, the new product chromatographic peaks appearing between 0.91
and 3.6 min retention times are shown in Table 2.

Figure 4. (a) TIC chromatograms for ART vs. ART-Fe2+ reaction obtained at room temperature. and at 37 ◦ C. (b) TIC
chromatograms of ART-deoxyadenosine-Fe2+ reaction obtained at room temperature and at 37 ◦ C.
Table 2. Retention times and fragmentation patterns of artemisinin in the presence of Fe2+ .
Retention Time

Main Fragments

0.91

265, 283, 305, 314, and 587

0.97

203, 209, 237, 265, 277, 283, 305, 314, 321 and 358

1.2

223, 300, 305, 314, 328, 356 and 587

1.4

203, 209, 251, 297, 332, 337, 346, 360, and 388

1.8

209, 251, 265, 315, 332, 337, 346, 353 and 360

2.5

203, 209, 224, 237, 251, 265, 279, 297, 337, 346, 358,
360 and 399

3.1

209, 251, 346, 360 and 374

3.6

203, 209, 224, 251, 265, 297, 346, 351, 360 and 374

From these mass spectra, it appeared that ART’s endo-peroxide bond opened up and
reacted with itself to form the many ART derived products observed. Based on the short
time this reaction took to happen, it appears to be occurring in a free radical fashion.
To establish whether this was the case, DNA bases were included in the mixture in
sections that follow below (Figure 4b). Interaction of ART with deoxyadenosine in the
presence of iron was monitored by observing chromatograms obtained from samples of
ART, deoxyadenosine and Fe2+ mixtures and after incubation at room temperature and
at 37 ◦ C. The sample mixtures were first analyzed immediately after mixing and then
again each day for three days. On the first day, several small chromatogram peaks were
obtained at about retention times 0.6, 0.8, 1.2 and 2.0 min (Figure 4b). The chromatographic
peaks at retention times 0.6 and 2.0 min were for deoxyadenosine and ART, respectively.
Chromatographic peaks at retention time 0.8 and 1.2 were product reaction peaks formed
from deoxyadenosine and ART at room temperature. On incubating the mixture at 37 ◦ C,
three new reaction peaks appeared at about 0.9, 1.4 and 1.8 min, with mass spectra quite
different from the previous results without Fe2+ ions. These new chromatographic reaction
product peaks grew with time of incubation at 37 ◦ C. Further analysis of these reaction
products was carried out using mass spectra; spectra of the reaction products corresponding
to Figure 4b are shown in Figure S2. Presence of deoxyadenosine was indicated by presence
of deoxyadenosine molecular ion [M+H]+ , similar to the previous result without Fe2+ .
Other ions include [M+Na]+ , [M+ K]+ , and [2M+Na]+ , corresponding to m/z of 274, 290
and 525, respectively. On the other hand, ART, with a molecular weight of 282 showed
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molecular ions [M+H]+ , at m/z 283, in addition to other ions such as [M+Na]+ , [M+K]+ ,
and [2M+Na]+ , corresponding to m/z of 305, 321 and 587, respectively.
The retention times and mass fragmentation patterns of products appearing between
retention times 0.8 and 1.8 min are given in Table 3.
Table 3. Retention times and fragmentation patterns of Deoxyadenosine reacted with artemisinin in
the presence of Fe2+ .
Retention Time (min)

Main Fragments (m/z)

0.8

252, 283, 305, 337, 367, 587, and 619

0.9

203, 209, 237, 252, 277, 283, 293, 305, 411, 531, and 547

1.2

223, 255, 279, 305, 314, 321, 356, 443 and 587

1.4

203, 217, 251, 252, 269, 291, 293, 297, 305, 319, 328, 337, 346,
and 370

1.8

203, 209, 251, 277, 337, 346, 353 and 360

These masses consist of those from ART as well as those from adenosine. The fact that
these masses are from different molecules than those observed when no iron was included
points to a different mechanism of formation for these molecules.
Based on the products formed, it was hypothesized that there is a difference in the
mechanism of the reaction between ART and deoxyadenosine when iron is present. In
general, iron II in the presence of hydrogen peroxide is known to form Fenton’s reagent [22].
We speculated that ART in the presence of iron II could also form a similar type of reaction.
When the endoperoxide in ART interacts with iron, it forms free radicals [10]. Activated
ART can react with the DNA base, forming adducts, and also reacts with itself, forming
dimers. As observed from the chromatogram and mass spectra, the products mediated by
free radical reactions are different from the products formed without the free radical route.
3.2. ART-Deoxycytidine
Chromatograms of the reaction of ART and deoxycytidine obtained at room temperature and at 37 ◦ C are given in Figure 5a. At day 0 (at room temperature), three
chromatogram peaks were obtained at about 0.5, 0.6 and 2.0 min. The peaks at 0.5 and
2.0 min belonged to deoxycytidine and ART, respectively, while the other at 0.6 min was
the reaction product of ART and deoxycytidine at room temperature. On subjecting the
mixture solution to 37 ◦ C, five new reaction peaks appeared at about 1.2, 1.4, 1.8, 3.1 and
3.6 min. The reaction product peaks grew with time of incubation at 37 ◦ C while the parent
peaks reduced. The initial reactant signature peaks decreased by about 6 to 60%, while
the new product peaks grew by about 100% during the time of incubation. The identity
of the reaction products was confirmed by observing the mass spectra of these molecules.
Figure S3 shows the mass spectra of chromatographic peaks shown in Figure 5. Deoxycytidine molecular ion [M+H]+ was observed at m/z 228. Other ions including [M+Na]+ ,
[2M+ H]+ , and [2M+Na]+ , corresponding to m/z of 250, 455 and 477, respectively. On the
other hand ART, with a molecular weight of 282, showed molecular ions [M+H]+ at m/z
283, in addition to other ions such as [M+Na]+ , [M+K]+ , [2M+Na]+ , corresponding to m/z
of 305, 321 and 587, respectively. The retention times and mass fragmentation patterns of
products appearing at retention times between 1.2 and 3.6 min are given in Table 4.
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S3 shows the mass spectra of chromatographic peaks shown in Figure 5. Deoxycytidine
molecular ion [M+H]+ was observed at m/z 228. Other ions including [M+Na]+, [2M+ H]+,
and [2M+Na]+, corresponding to m/z of 250, 455 and 477, respectively. On the other hand
ART, with a molecular weight of 282, showed molecular ions [M+H]+ at m/z 283, in addition to other ions such as [M+Na]+, [M+K]+, [2M+Na]+, corresponding to m/z of 305, 321
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Table 4. Retention times and main fragmentation patterns of Deoxycytidine reacted with artemisinin.
Retention Time

Main Fragments (m/z)

1.2

203, 209, 284, 291, 305, 323, 332 and 337

1.4

203, 224, 245, 251, 284, 291, 337, 346, 360, and 388

1.8

209, 251, 277, 337 and 346

3.1

209, 251, 277, 284, 307, 346, 351, 360 and 374

3.6

209, 251, 277, 297, 307, 351, 360 and 374

Alkylation most likely occurs in the reaction between the drug and the DNA base,
which leads to the formation of ART-deoxycytidine adducts. In principle, alkylation of 20 deoxycytidine can occur at nitrogen atoms, N3 and N4, and at the oxygen atom. Alkylation
at multiple location in deoxycytidine could be one of the key reasons for encountering
different molecules representing the same masses in the mass spectra. These adducts
undergo mass fragmentation and are represented by the reaction peaks indicating presence
of both deoxycytidine and ART mass fragmented ions. It is possible that the mechanism
of deoxycytidine (dC) alkylation at N3, N4, and O2 positions by ART occurred under
temperature control. Figure S4 shows deoxycytidine alkylation on the N3, N4, and O2
positions by Artemisinin (ART). This kind of alkylation mechanism on deoxycytidine was
previously reported in [23,24]. Studies show that alkylation at the N3 position is favored in
reaction in water, and can be reversible and less stable compared to N4, whereas under
thermodynamic control N4 alkylation will be more likely to take place. Alkylation at the
O2 position was proposed even though it is less likely [23].
Free interaction of ART with deoxycytidine in the presence of iron was monitored
by obtaining chromatograms of mixtures of theses samples after incubation at room temperature and at 37 ◦ C. The chromatograms obtained are given in Figure 5b. The sample
mixtures were first analysed immediately after mixing, then analysed again each day for
four days. On the first day, several chromatogram peaks were obtained at about retention
times 0.5, 0.8, 1.2 and 2.0 min. The chromatographic peaks at retention times 0.5 and 2.0 min
were for deoxycytidine and ART, respectively. The chromatographic peak at retention time
at 1.2 min was from ART with Fe2+ . On incubating the mixture at 37 ◦ C, seven new reaction
peaks appeared at about 0.9, 1.3, 1.4, 1.8, 2.1, 3.1 and 3.6 min. These new chromatographic
reaction product peaks grew with time of incubation at 37 ◦ C. Further analysis of these
reaction products was carried out using mass spectra.
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The mass spectra of the chromatographic peaks shown in Figure 5b are given in
the supplemental information (Figure S5). Deoxycytidine molecular ion [M+H]+ was
observed at m/z 228. Other ions included [M+Na]+ , [2M+H]+ , [2M+Na]+ and [2M+K]+ ,
corresponding to m/z of 250, 455, 477 and 493, respectively. On the other hand ART, with
a molecular weight of 282, showed molecular ions [M+H]+ , at m/z 283, in addition to
other ions such as [M+Na]+ , [M+K]+ , [2M+Na]+ , corresponding to m/z of 305, 321 and 587,
respectively. The m/z for the reaction products observed at 0.8, 0.9, 1.2, 1.3, 1.4, 1.8, 2.1, 3.1
and 3.6 min are given here. The new product chromatographic peaks and fragmentation
patterns appearing between 0.8 and 3.6 min are shown in Table 5.
Table 5. Fragmentation patterns of the products of deoxycytidine reacted with artemisinin in the
presence of Fe2+ .
Retention Time

Main Fragments (m/z)

0.8

283, 305, 314, 337, 587, and 619

0.9

209, 237, 277, 283, 293, 305, and 531

1.2

223, 305, 314, 321, 356, 587 and 605

1.3

251, 291, 300 and 307

1.4

251, 291, 297, 307, 319, 337, 346, 353, 360, 374
and 388

1.8

251, 277, 297, 337, 346, and 353

2.1

209, 237, 265, 283, 305, 337, 346, 353 and 356

3.1

251, 346, 351, 360, 367 and 374

3.6

251, 277, 297, 307, 351, 360, 367 and 374.

4. Discussion
Based on the products formed, it was clear there was a difference in the mechanism of
the reaction between ART and the DNA bases when iron was present. In general, iron II in
the presence of hydrogen peroxide is known to form Fenton’s reagent [22]. We speculated
that ART in the presence of iron II could also form a similar type of reaction. When the
endoperoxide in ART interacts with iron, it forms free radicals [10]. Activated ART reacts
with the DNA base, forming adducts, and also reacts with other molecules, including itself,
to form dimers. As observed from the chromatograms and mass spectra, the products
mediated by free radical reactions are different from the products formed without free
radical route. The two reactions most likely proceed side by side when ART is administered
for the treatment of various diseases. A study of the molecular transformation of ART
moiety in the presence of a host of biological molecules would definitely open up new
understanding of molecular pathways involving ART and its derivatives, and hence help
to tailor new therapies. ART is one the few exceptions that work non-stereo specifically,
enabling easy laboratory synthesis of active forms of the drug.
5. Conclusions
Understanding the mechanism of reaction involving ART and DNA can help unravel
potential reactions when these drugs are administered. In this work, we have explored
the interactions of ART with DNA bases, ART with Fe2+ , and ART with both DNA and
Fe2+ . Reaction of ART with DNA bases was found to give rise to new adducts, as observed
from new chromatographic peaks showing both the DNA base and ART signatures. These
reactions were only observed when the mixture was incubated at 37 ◦ C. Incubation of ART
with Fe2+ caused the formation of several new molecules, indicating breakdown of the
peroxide bond. Formation of new reaction products was not time dependent, as observed
from chromatograms typical of free radical reactions. Study of ART and its derivatives
with biological molecules is key to understanding the drug’s activity in vivo.
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Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/separations8090161/s1, Figure S1. Mass spectrum of artemisinin-deoxyadenosine reaction
products at 0.7 min (A), 0.8 min (B), 0.9 min (C), 1.1 min (D) and 1.2 min (E). Figure S2. Mass
spectrum of artemisinin-deoxyadenosine- Fe2+ at 0.8 min (A), 0.9 min (B), 1.2 min (C), 1.4 (D), and
1.8 (E). Figure S3. Mass spectrum of artemisinin-deoxycytidine reaction products at 1.2 min (A),
1.4 min (B), 1.8 min (C), 3.1 min (D), and 3.6 min (E). Figure S4. Possible mechanism of deoxycytidine
(dC) alkylation on the N3, N4, and 2O positions by Artemisinin (ART) under temperature control.
Figure S5: Mass spectrum of artemisinin-deoxycytidine-Fe2+ at 0.8 min (A), 0.9 min (B), 1.2 min (C),
1.3 min (D), 1.4 (E), 1.8 (F), 2.1 (G), 3.1 (H) and 3.6 (I). Table S1. Identification of mass fragments
of artemisinin-deoxyadenosine reaction products. Table S2. Identification of mass fragments of
artemisinin-deoxyadenosine-Fe2+ reaction products.
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